Skip to main content
Psychedex

1Provenance card

the boundary, as counts

Sources

1912 with DOI

5 strong · 10 moderate · 4 weak

Compilations

12026-04-26T19:09:32.750Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:29:19.637Z

notice · info card · emergency

Searches

171 with no results

queries and counts on the build

Claims checked

4833 supported

33 supported · 15 not

Correspondence

0received

consent field ships in Phase 4

Edges

179

derivations recorded for this entity

Complete over 19 sources, 1 compilation, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/2c-d/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-24srcInteractions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases
  5. 2026-09-24srcChemistry and Structure-Activity Relationships of Psychedelics.
  6. 2026-09-24srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
  7. 2026-09-24srcHallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
  8. 2026-09-24srcBehavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function
  9. 2026-09-24srcAnalysis of 2,5-dimethoxy-amphetamines and 2,5-dimethoxy-phenethylamines aiming their determination in biological matrices: a review.
  10. 2026-09-24src2C or Not 2C: Phenethylamine Designer Drug Review
  11. 2026-09-24srcSafety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances
  12. 2026-09-24srcNew psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.
  13. 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
  14. 2026-09-24src1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents - A Review.
  15. 2026-09-24srcThe 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects
  16. 2026-09-24srcSerotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release
  17. 2026-09-24srcSerotonin and hallucinogens
  18. 2026-09-24srcSynthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands
  19. 2026-09-24srcSynthetic Drug Abuse Prevention Act of 2012 (within FDASIA, P.L. 112-144)
  20. 2026-09-24src2C-D - Wikipedia
  21. 2026-09-24src2C-D - Wikidoc
  22. 2026-09-24src2C-D (hydrochloride) - Cayman Chemical Product 11888
  23. 2026-09-04issueIssued emergency
  24. 2026-09-04issueIssued info_card
  25. 2026-09-04issueIssued notice
  26. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  27. 2026-06-04publicationPublication — backfill
  28. 2026-04-26revisionRevision 1
  29. 2026-04-26absenceSearched ClinicalTrials.gov for "2C-D phenethylamine psychedelic" — no results
  30. 2026-04-26genGeneration — pipeline-v5pipeline-v5
  31. 2026-04-26rungeneration run

The same entries, as forms: six forms.